[go: up one dir, main page]

AR118602A1 - TRIESPECIFIC AND / OR TRIVALENT BINDING PROTEINS FOR THE TREATMENT OF HIV INFECTION - Google Patents

TRIESPECIFIC AND / OR TRIVALENT BINDING PROTEINS FOR THE TREATMENT OF HIV INFECTION

Info

Publication number
AR118602A1
AR118602A1 ARP200100963A ARP200100963A AR118602A1 AR 118602 A1 AR118602 A1 AR 118602A1 AR P200100963 A ARP200100963 A AR P200100963A AR P200100963 A ARP200100963 A AR P200100963A AR 118602 A1 AR118602 A1 AR 118602A1
Authority
AR
Argentina
Prior art keywords
binding proteins
trivalent
treatment
triespecific
hiv infection
Prior art date
Application number
ARP200100963A
Other languages
Spanish (es)
Original Assignee
Sanofi Sa
Us Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa, Us Health filed Critical Sanofi Sa
Publication of AR118602A1 publication Critical patent/AR118602A1/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

En el presente documento se proporcionan composiciones que comprenden proteínas de unión triespecíficas y/o trivalentes que comprenden cuatro cadenas polipeptídicas que forman tres sitios de unión a antígeno que se unen específicamente a una o más proteínas diana del VIH, en las que un primer par de polipéptidos que forman la proteína de unión poseen dominios variables dobles que tienen una orientación cruzada, y en la que el segundo par de polipéptidos posee un dominio variable único. También se proporcionan en el presente documento métodos para preparar proteínas de unión triespecíficas y/o trivalentes y usos de dichas proteínas de unión para el tratamiento y/o la prevención del VIH / SIDA.Provided herein are compositions comprising trivalent and / or trivalent binding proteins comprising four polypeptide chains that form three antigen-binding sites that specifically bind to one or more HIV target proteins, wherein a first pair of polypeptides that make up the binding protein possess dual variable domains that are cross-oriented, and wherein the second pair of polypeptides possesses a single variable domain. Also provided herein are methods for preparing trivalent and / or trivalent binding proteins and uses of such binding proteins for the treatment and / or prevention of HIV / AIDS.

ARP200100963A 2019-04-09 2020-04-06 TRIESPECIFIC AND / OR TRIVALENT BINDING PROTEINS FOR THE TREATMENT OF HIV INFECTION AR118602A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201962831415P 2019-04-09 2019-04-09

Publications (1)

Publication Number Publication Date
AR118602A1 true AR118602A1 (en) 2021-10-20

Family

ID=78803843

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP200100963A AR118602A1 (en) 2019-04-09 2020-04-06 TRIESPECIFIC AND / OR TRIVALENT BINDING PROTEINS FOR THE TREATMENT OF HIV INFECTION

Country Status (1)

Country Link
AR (1) AR118602A1 (en)

Similar Documents

Publication Publication Date Title
CO2018005337A2 (en) Trispecific and / or trivalent binding proteins for the prevention or treatment of HIV infection
CO2018012107A2 (en) Trispecific and / or trivalent binding proteins
CO2020016559A2 (en) Antibodies that target hiv gp120 and methods of use
EA202091130A1 (en) LYOPHILIZED PREPARATION OF MONOCLONAL ANTIBODY TO TRANSTYRETIN
CO2021014918A2 (en) Trispecific binding proteins, methods and uses thereof
CO2021014988A2 (en) Trispecific and/or trivalent binding proteins using the crossover dual domain variable (codv) format for the treatment of hiv infection
EP3970747A3 (en) Compositions and methods for treating and preventing staphylococcus aureus infections
MX395074B (en) Anti-AXL antibodies, antibody fragments and their immunoconjugates and their uses
BR112016015867A2 (en) high affinity and aggregation resistant antibodies based on variable regions vl and derivative vhh
MX2020011027A (en) CONSTRUCTS OF TRIVALENT BISECIFIC ANTIBODIES.
BR112020015498A8 (en) ANTI-PD-1 ANTIBODIES
AR128564A1 (en) ANTIBODIES
MY192090A (en) Trispecific and/or trivalent binding proteins
AR118602A1 (en) TRIESPECIFIC AND / OR TRIVALENT BINDING PROTEINS FOR THE TREATMENT OF HIV INFECTION
BR112022005787A2 (en) Antigen binding proteins
ECSP18039758A (en) TRIESPECIFIC AND / OR TRIVALENT BINDING PROTEINS FOR THE PREVENTION OR TREATMENT OF HIV INFECTION
ECSP18084491A (en) TRIESPECIFIC AND / OR TRIVALENT BINDING PROTEINS
EA202191078A2 (en) TRISSPECIFIC AND / OR TRIVALENT BINDING PROTEINS FOR PREVENTION OR TREATMENT OF HIV INFECTION
AR108210A1 (en) THREE-SPECIFIC AND / OR TRIVAL UNION PROTEINS